HirotoInabaMD

Pediatric Hematology & Oncology • Memphis, TN

Member, Leukemia/Lymphoma Division, Department of Oncology, St. Jude Children's Research Hospital Professor, Department of Pediatrics, University of Tennessee Health Science Center College of Medicine

Join to view full profile

Dr. Inaba is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Inaba's full profile

Already have an account?

Office
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105

Education & Training

University of TennesseeFellowship, Pediatric Hematology/Oncology, 2003 - 2006
Children's Hospital of MichiganResidency, Pediatrics, 2000 - 2003
OtherClass of 1991

Certifications & Licensure

TN State Medical License 2003 - 2026
MI State Medical License 2000 - 2003
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies Start of enrollment: 2009 Sep 01
Completed
Phase 1
NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma Start of enrollment: 2012 May 25
Completed
Phase 2
Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma Start of enrollment: 2017 Mar 29
Active, not recruiting
Phase 2, Phase 3
Expanded Access Program for Revumenib
Available
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Clinical Actionability of the NUDT15 *4 (p.R139H) Allele and Its Association With Hispanic Ethnicity.
Maud Maillard, Jenny Q Nguyen, Wenjian Yang, Keito Hoshitsuki, Mary V Relling
Clinical Pharmacology and Therapeutics. 2024-12-17
Treatment of a pediatric patient with concurrent neuroblastoma and acute lymphoblastic leukemia.
Megan M Lilley, Marta Salek, Ashley Holland, Hiroto Inaba, Sara M Federico
Pediatric Blood & Cancer. 2024-12-01
Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia.
Charles Mullighan, Ruth Wangondu, Emily Ashcraft, Ti-Cheng Chang, Kathryn Roberts
Research Square. 2024-11-11

Journal Articles

Association of Bacteremic Sepsis with Long-Term Neurocognitive Dysfunction in Pediatric Patients with Acute Lymphoblastic Leukemia
Hiroto Inaba, Joshua Wolf, Kevin R Krull, Melissa M Hudson, JAMA

Abstracts/Posters

Acute Lymphoblastic Leukemia with Zinc-Finger Protein 384 (ZNF384)-Related Rearrangements: A Retrospective Analysis from the Ponte Di Legno Childhood ALL Working Group
Hiroto Inaba, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Traumatic and Bloody Lumbar Puncture at Diagnosis in Children with Acute Lymphoblastic Leukemia: A St. Jude Total XV and Total Xvi Cohort Study
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Clinical Trial Results Show Low-Intensity Therapy Can Achieve Positive Outcomes for Certain Pediatric Leukemia SubtypesSeptember 24th, 2024
Celebrating Doctors’ Day: St. Jude Physicians Reflect on Their Career OriginsMarch 30th, 2021
Clinical Characteristics and Outcomes of B-ALL with ZNF384 Rearrangements: A Retrospective Analysis by the Ponte Di Legno Childhood ALL Working GroupMarch 10th, 2021
Join now to see all